Sanofi Chief Executive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanofi chief executive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanofi Chief Executive Today - Breaking & Trending Today

Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development


Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas
Fast tracks establishment of Sanofi’s recently announced 
mRNA Center of Excellence
Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology
PARIS and LEXINGTON, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio (NASDAQ: TBIO), a clinical-stage mRNA therapeutics company, under which Sanofi will acquire all outstanding shares of Translate Bio for $38.00 per share in cash, which represents a total equity value of approximately $3.2 billion (on a fully diluted basis). The Sanofi and T ....

France General , Eva Schaefer Jansen , Arnaud Delepine , Suzanne Greco , Felix Lauscher , Maura Gavaghan , Fara Berkowitz , Sanofi Pasteur , Ashleigh Koss , Paul Hudson , Nathalie Pham , Sandrine Guendoul , Teri Dahlman , Ronald Renaud , Exchange Commission , Wharton Garrison , Baupost Group , Health Partners , Gotshal Manges , Morgan Stanley Co , Rna Center , Translate Bio , Translate Bio Boards , Sanofi Chief Executive , Chief Executive Officer , Tidal Therapeutics ,

Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L


 
Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words expects , anticipates , believes , intends , estimates , plans , will be and similar expressions. Although Sanofi s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to ....

United Kingdom , France General , Eva Schaefer Jansen , Arnaud Delepine , Suzanne Greco , Felix Lauscher , Simon Sturge , John Reed , Yvonne Naughton , Brandon Lewis , Fara Berkowitz , Ashleigh Koss , Paul Hudson , Quentin Vivant , Anne Hyland , Global Head Of Research Development At Sanofi , Gotshal Manges , Consilium Strategic Communications , Sanofi Chief Executive , Chief Executive Officer , Eczema Area , Severity Index , Global Head , Hart Scott Rodino Antitrust Improvements Act , Intelliselect Transgenic , Jane Elliott ,